Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 3771249 in advanced or metastatic KRAS G12D-mutant colorectal cancer
NL-OMON61219Phase 1Recruiting
- Sponsor
- Bayer Consumer Health
- Start
- Oct 2026
- Modality
- Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of KQB548 in colorectal adenocarcinoma, sponsored by Bayer Consumer Health. Primary endpoint: Primary endpoint(s). Started Oct 2026; status: recruiting.
02
Drugs
KQB548
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NL-OMON61219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61219.